Resmed Inc Drc Stock Cash Per Share
| RMD Stock | 38.15 0.25 0.65% |
Resmed Inc DRC fundamentals help investors to digest information that contributes to Resmed's financial success or failures. It also enables traders to predict the movement of Resmed Stock. The fundamental analysis module provides a way to measure Resmed's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Resmed stock.
Resmed | Cash Per Share |
Resmed Inc DRC Company Cash Per Share Analysis
Resmed's Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
| Competition |
Resmed Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
In accordance with the recently published financial statements, Resmed Inc DRC has a Cash Per Share of 0.0 times. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The cash per share for all Australia stocks is 100.0% higher than that of the company.
Did you try this?
Run Price Exposure Probability Now
Price Exposure ProbabilityAnalyze equity upside and downside potential for a given time horizon across multiple markets |
| All Next | Launch Module |
Resmed Fundamentals
| Return On Equity | 0.24 | ||||
| Return On Asset | 0.13 | ||||
| Profit Margin | 0.23 % | ||||
| Operating Margin | 0.32 % | ||||
| Current Valuation | 56.84 B | ||||
| Shares Outstanding | 1.47 B | ||||
| Shares Owned By Institutions | 10.49 % | ||||
| Price To Book | 7.01 X | ||||
| Price To Sales | 11.65 X | ||||
| Revenue | 4.69 B | ||||
| Gross Profit | 2.39 B | ||||
| EBITDA | 1.53 B | ||||
| Net Income | 1.02 B | ||||
| Cash And Equivalents | 273.71 M | ||||
| Total Debt | 873.93 M | ||||
| Book Value Per Share | 35.39 X | ||||
| Cash Flow From Operations | 1.4 B | ||||
| Earnings Per Share | 1.16 X | ||||
| Price To Earnings To Growth | 1.88 X | ||||
| Target Price | 25.93 | ||||
| Beta | 0.69 | ||||
| Market Capitalization | 55.99 B | ||||
| Total Asset | 6.87 B | ||||
| Retained Earnings | 4.99 B | ||||
| Working Capital | 1.45 B | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 6.87 B | ||||
| Last Dividend Paid | 1.97 |
About Resmed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Resmed Inc DRC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Resmed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Resmed Inc DRC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Resmed Stock Analysis
When running Resmed's price analysis, check to measure Resmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Resmed is operating at the current time. Most of Resmed's value examination focuses on studying past and present price action to predict the probability of Resmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Resmed's price. Additionally, you may evaluate how the addition of Resmed to your portfolios can decrease your overall portfolio volatility.